SLC5A2 and Glycosuria: Non-diabetic individuals treated with an SGLT2 inhibitor do not experience hypoglycaemia for the same reasons, and similarly, hypoglycaemia is not an issue for people with benign familial glycosuria; a genetic condition due to a mutation in SGLT2.